2004

• Jan
• Feb
• Mar
• Apr
• May
• June
• July
• Aug
• Sept
• Oct
• Nov
• Dec

December

	Warning not to use Lot 4G03 Artificial Tears Extra Date: 2004/12/29
	Safety information regarding selective COX-2 inhibitor NSAIDs: Vioxx (rofecoxib), Celebrex (celecoxib), Bextra (valdecoxib), Mobicox (meloxicam) and generic forms of meloxicam Date: 2004/12/22
	Medication errors involving Reminyl and Amaryl Janssen-Ortho Inc. and Aventis Pharma Inc Date: 2004/12/21
	Updated safety information on increased cardiovascular risk with Celebrex* (celecoxib) Date: 2004/12/20
	Updated safety: Possible relationship of Aredia and/or Zometa with osteonecrosis of the jaw - Novartis Pharma Canada Inc. Date: 2004-12-15
	Pfizer Canada Inc. Issues Warnings about Bextra - Cardiovascular Risks and Serious Skin Reactions - Pfizer Canada Inc. Date: 2004-12-10
	Health Canada warns Canadians that certain lots of a sedative (Novo-Lorazem) may contain pills of a different drug Date: 2004-12-03
	Updated Safety Information addressing the risk of malignancies associated with REMICADE (infliximab) -Schering Canada Inc. Date: 2004-12-02

November

	Urgent Product Removal Oral-B CrossAction Power and PowerMAX Toothbrushes and refills. - Gillette Date: 2004-11-30
	Health Canada warns consumers not to use Male Power Plus Date: 2004-11-26
	Updated Safety Information regarding Crestor® Date: 2004-11-24
	Health Canada warns against using Blue Cap shampoo and spray Date: 2004-11-20
	Notification to CLARION 1.2 cochlear implant users. - Advanced Bionics Date: 2004-11-09
	Notification to CLARION CII cochlear implant users. - Advanced Bionics Date: 2004-11-09
	Notification to HiRes 90K cochlear implant users. - Advanced Bionics Date: 2004-11-09
	Safety Information on the LTV Series Ventilators - Pulmonetic Systems Date: 2004-11-04
	Health Canada advises consumers to consult with their physicians on the use of Carbolith 150 milligram products Date: 2004-11-01

October

	Urgent Product Removal Oral-B CrossAction Power and PowerMAX Toothbrushes and refills. - Gillette Date: 2004-10-29
	New Warnings about Parkinson's Drug PERMAX® and Reports of Heart Valve Problems - Shire BioChem Inc. Date: 2004-10-26
	Association of EPREX (epoetin alfa) with thrombotic vascular events -Janssen-Ortho Inc. Date: 2004-10-18

September

	Health Canada informs Canadians of Vioxx withdrawal by Merck & Co. Date: 2004/09/30
	Important safety information for patients taking LAMICTAL (lamotrigine) - GlaxoSmithKline Inc. Date: 2004-09-27
	Health Canada Advises Consumers to Return Euro-K and Riva-K Potassium Chloride Products Date: 2004-09-01

August

	Mallinckrodt, a division of Nellcor/Tyco Healthcare Issues Recall of TracheoSoft XLT Extended Length Tracheostomy Tube -Tyco Healthcare Date: 2004-08-20
	Health Canada advises of potential adverse effects of SSRIs and other anti-depressants on newborns Date: 2004-08-09

July

	Possible Association between RITUXAN (rituximab) and the recurrence of Hepatitis B - Hoffmann-La Roche Limited Date: 2004-07-30
	Health Canada advises consumers not to use the products containing ARISTOLOCHIC ACID Date: 2004-07-27
	Health Canada Warns Canadians Not to Use "SESA Hair Supplement" Date: 2004-07-27
	Health Canada is advising Canadians that antidepressant TRAZODONE may interact with certain medications Date: 2004-07-08

June

	Health Canada Advises Consumers Not to Ingest Teas or Health Products Containing STAR ANISE Unless it Is Identified as Chinese Star Anise Date: 2004-06-29
	ARAVA (leflunomide) and lung inflammation causing difficulty breathing Date: 2004-06-24
	Health Canada Takes Additional Safety Measures to Ensure the Safe Use of CLOZAPINE Date: 2004-06-24
	Health Canada Is advising Canadians about a possible association between CRESTOR and rhabdomyolysis - AztraZeneca Canada Inc. Date: 2004-06-24
	Health Canada advises health professionals and consumers about PENICILLIN allergy test recall Date: 2004-06-18
	Health Canada is advising health professionals and patients regarding the recall of specific batches of PROGLYCEM® Date: 2004-06-04
	Health Canada advises Canadians of stronger warnings for SSRIs and other newer anti-depressants Date: 2004-06-03

May

	Health Canada warns public not to use Thermonex Date: 2004-05-28
	Health Canada warns public not to use Bell Magnum Bullet Date: 2004-05-26
	Important New Safety Information on ORTHOCLONE OKT*3 (muromonab-CD3) - Janssen-Ortho Inc. Date: 2004-05-17
	Emerging Safety Information: Diarrhea and Ischemic Colitis in Patients Using ZELNORM (tegaserod hydrogen maleate) - Novartis Pharmaceuticals Canada Inc. Date: 2004-05-13

April

Important Safety Information concerning Liver Problems for Patients taking ACCOLATE® (zafirlukast) - AstraZeneca Canada Inc. Date: 2004-04-19

March

Updated Safety Information for ZYPREXA (olanzapine) in Elderly Dementia Patients, Announced in Canada - Eli Lilly Canada Inc. Date: 2004-03-18

February

	Health Canada advises Canadians under the age of 18 to consult physicians if they are being treated with newer anti-depressants Date: 2004-02-03
	PUBLIC ADVISORY - Information for patients regarding a drug interaction between RITONAVIR (Norvir/Kaletra) and FLUTICASONE propionate (Flonase, Flovent, Advair) - GlaxoSmithKline Inc. Date: 2004-02-02

January

	PUBLIC ADVISORY - Updated Safety Information Announced in Canada for Patients Taking TOPAMAX* (topiramate) Regarding Higher than Normal Blood Acid Levels - Janssen-Ortho Inc. Date: 2004-01-26
	PUBLIC ADVISORY - Updated Safety Information about EPREX* (epoetin alfa) Provided to Canadian Healthcare Professionals - Janssen-Ortho Inc. Date: 2004-01-15
	Serious liver injury with TEBRAZID (pyrazinamide) or PMS-pyrazinamide and rifampin for the treatment of latent tuberculosis - ICN Canada Limited and Pharmascience Inc. Date: 2004-01-06